Fluocinonide(Vanos) reduced MTT turnover dose-dependently in mouse subventricular-zone neural stem cells versus control cells, and cyclopamine reversed these effects. Mouse Shh-LIGHT2 cells responded robustly to Fluocinonide(Vanos), with Fluc/Rluc activity as the readout. In the neural stem cell growth study, Fluocinonide(Vanos) did not reproduce the reported clobetasol-associated effect on the rate of cell growth. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
MTT turnover in NSCs were derived from the subventricular zone (SVZ) of 8–12 weeks old (20–24 g) male 129/SV mice
Cell-based study · NSCs were derived from the subventricular zone (SVZ) of 8–12 weeks old (20–24 g) male 129/SV mice [1]
Model: NSCs were derived from the subventricular zone (SVZ) of 8–12 weeks old (20–24 g) male 129/SV mice. Treatment: 0.1–25 μM. Result: fluocinonide (0.1–25 μM): dose-dependent reduction in MTT turnover. These effects were reverted by cyclopamine..
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.1–25 μM
- Exposure duration
- 1–4 days
- Method
- cells were exposed to drugs
- Vehicle
- cell culture media
- Co-treatment
- Other interventions in this design: EGF 20 ng/mL; bFGF 10 ng/mL; heparin 2 μg/mL. Compound effect isolated by the comparison: vs. control.
Methods and source locations
Compound reported in the paper: Fluocinonide(Vanos); Compound label in the paper: fluocinonide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Results > 2.3. Clobetasol Increases Proliferation and Dimension of NSCs Neurospheres (S24, S25); 4. Materials and Methods > 4.1. Neural Stem Cell Derivation and Culture (S37, S41); 4. Materials and Methods > 4.2. Shh Pathway Modulation in NSCs (S46, S47, S48); 4. Materials and Methods > 4.3. LDH and MTT Cytotoxicity/Viability Assays (S49, S53, S56); Figure 5 legend (S107, S108)
MTT turnover: MTT turnover; comparator: control cells — 2. Results > 2.3. Clobetasol Increases Proliferation and Dimension of NSCs Neurospheres (S24, S25); 4. Materials and Methods > 4.2. Shh Pathway Modulation in NSCs (S47); Figure 5 legend (S107)
Robust response to fluocinonide in mouse reporter cells
Cell-based study · mouse Shh-LIGHT2 cells [2]
Mouse Shh-LIGHT2 cells were treated with Fluocinonide(Vanos), with Fluc/Rluc activity as the readout. The cells responded robustly to treatment.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 uM
- Method
- in DMEM containing 0.5% calf serum
- Reported limits
- Not stated in the sentences used: schedule, vehicle.
Methods and source locations
Compound reported in the paper: Fluocinonide(Vanos); Compound label in the paper: fluocinonide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Primary screen for chromosome 21 cDNAs that affect SHH signaling (S12, S13); MATERIALS AND METHODS > Luciferase reporter assays (S106); Fig. 2. legend (S160)
Fluc/Rluc activity: Fluc/Rluc activity; comparator: induction media control — RESULTS > Primary screen for chromosome 21 cDNAs that affect SHH signaling (S13); MATERIALS AND METHODS > Luciferase reporter assays (S106); Fig. 2. legend (S160)
Fluocinonide and neural stem cell growth
Cell-based study · NSCs were derived from the subventricular zone (SVZ) of 8–12 weeks old (20–24 g) male 129/SV mice [1]
Neural stem cells derived from the subventricular zone of male mice were exposed to Fluocinonide(Vanos), with untreated cells as the control. Fluocinonide(Vanos) did not reproduce the reported clobetasol-associated effect on the rate of cell growth.
Literature-Reported Treatment Conditions
- Treatment concentration
- 5 μM
- Exposure duration
- 1–4 days
- Method
- cells were exposed to drugs
- Vehicle
- cell culture media
- Co-treatment
- Other interventions in this design: EGF 20 ng/mL; bFGF 10 ng/mL; heparin 2 μg/mL. Compound effect isolated by the comparison: vs. untreated control.
Methods and source locations
Compound reported in the paper: Fluocinonide(Vanos); Compound label in the paper: fluocinonide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Results > 2.3. Clobetasol Increases Proliferation and Dimension of NSCs Neurospheres (S22, S26); 4. Materials and Methods > 4.1. Neural Stem Cell Derivation and Culture (S37, S41, S43); 4. Materials and Methods > 4.2. Shh Pathway Modulation in NSCs (S46, S48); Figure 5 legend (S107, S109, S111)
NSCs rate of cell growth (RCG): NSCs rate of cell growth (RCG); comparator: untreated control — 2. Results > 2.3. Clobetasol Increases Proliferation and Dimension of NSCs Neurospheres (S26); Figure 5 legend (S109)